Felix Registration Achieved in Turkey, Sales Commence
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Memphasys Ltd has announced the successful registration of its Felix™ System in Turkey, allowing for the commencement of commercial sales under the ITL agreement. The initial sale includes a significant number of cartridges and consoles, marking the start of operations in a large assisted-reproduction market. The company has completed training for local distributors to facilitate product demonstrations and further sales growth in Turkey. Memphasys expects additional orders as IVF clinics engage with their commercial partners in the region.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Memphasys
- EUR526,500 Nordic Agreement Expands Felix European Footprint
- Felix Early Thai FDA Approval, Commercial Launch Accelerates
- Felix Registration Achieved in Vietnam and Cartridge Order
- European Commercial Roll-out continues with Poland Agreement
- Exclusive Thailand Commercialisation Agreement Secured
Later from Memphasys
- Memphasys Secures European Felix Agreement
- Potential Expedited FDA Pathway to US IVF Market
- Memphasys receives A$3.5 million from Peters Investments
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys